Work

Superiority of Immunotherapy to Benzodiazepines and No Treatment in Down Syndrome Regression Disorder (P8-6.007)

Year: 2025

Type: article

Source: Neurology

DOI: 10.1212/wnl.0000000000208699

Authors: Jonathan Santoro, Saba Jafarpour, Panteha Hayati Rezvan, Mellad Khoshnood, Natalie Boyd, Benjamin Vogel, Lina Nguyen, Lilia Kazerooni, Noemi Spinazzi, Nidhiben Anadani, Kristen Fisher, Robyn Filipink, Melanie Manning, Cathy Franklin, Eileen Quinn, Michael Rafii

Institutions: Children's Hospital of Los Angeles, University of California, San Francisco, University of Oklahoma Health Sciences Center, University of Oklahoma, Baylor College of Medicine, Children's Hospital of Pittsburgh, Stanford Medicine, Stanford University, Mater Research, University of Toledo, University of Southern California

Language: English

Topic: Down syndrome and intellectual disability research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409222648

FWCI:

Cites:

Cited by:

Related to: 10